RA Capital
Venture capitalBoston · Seed–Late Stage · 11 people tracked
Team · 11 people
from the firm's websiteWhat they invest in
from 19 of 263 portfolio companiesBiotech ×11Medical Devices ×10AI & Machine Learning ×6Deep Tech ×6Healthtech ×6Digital Health ×3SaaS ×3Enterprise Software ×2
HQs:United States×8United Kingdom×1
Investments · showing 60 of 263
founders shown can be your intro pathAvalanche Energy develops compact fusion technology to generate high-energy neutrons for materials testing, radioisotope production, and advanced nuclear battery systems serving defense, space, and commercial power applications. The company also provides high-voltage vacuum components and operates FusionWERX, a commercial-scale fusion testing facility.
Deep TechDefense TechEnergyRichland, US
Robin Langtry
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Riley Ennis(Co-Founder and Chief Product Officer)
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)
Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types. The company adopts a capital-efficient approach to advance novel cancer therapeutics, with potential applications also in fibrotic disease.
BiotechHealthtechMedical DevicesSan Mateo, US
<UNKNOWN>
Ambagon develops small molecule stabilizers of 14-3-3 protein complexes to modulate disease-related protein interactions, targeting therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.
BiotechDeep TechMedical Devices
Ansa Biotechnologies develops an enzyme-based process to manufacture DNA, offering an alternative to the established chemical synthesis methods used in the industry. The technology targets research and industrial applications across therapeutics, diagnostics, and biological production.
BiotechHealthtechEmeryville, US
Apeiron Labs develops autonomous underwater vehicles and ocean technology for marine applications. The company builds deep-tech solutions for ocean exploration and resource management.
Climate TechDeep TechIoTRobotics
Ravi Pappu(CEO / Board Member)
Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Jennifer Doudna(Co-founder, Nobel Laureate in Chemistry and Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences, UC Berkeley)Rodolphe Barrangou(Co-founder, Associate Professor of Medicine, UCSF)Krishnendu Roy(Co-founder, Professor of Bioengineering, Stanford University)
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases. The company uses data-driven approaches and bioinformatics to identify and develop its pipeline of aging-focused therapeutics.
BiotechHealthtechLongevity
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)
Frequently asked questions
- What stage does RA Capital invest at?
- RA Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does RA Capital focus on?
- RA Capital focuses on Biotech, Medical Devices.
- Where is RA Capital located?
- RA Capital is headquartered in Boston, US.